Innovative therapeutics

Investors

Investor FAQs

 

Biomarin's ticker is BMRN and it is traded on Nasdaq.

105 Digital Drive
Novato, CA 94949
United States

You can view our Board of Directors by visiting the Board of Directors section of our Investor Relations website.

You can view our management team by visiting the Management section of our Investor Relations website.

31 December

Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financial Information portion of our Investor Relations website or directly from the SEC at www.sec.gov.

BioMarin does not currently have a direct stock purchase plan.

Please submit your question using the form below.

* Indicates required field
img_bottom-content

Diseases

MPS I, MPS VI, PKU, LEMS, Lysosomal Storage Disorders, Morquio A/MPS IVA

Products

VIMIZIM™, Kuvan®, Naglazyme®, Aldurazyme®, Firdapse®

Patient/Physician Contact Information

BioMarin Patient and Physician Support (BPPS)
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: bpps@bmrn.com

Top